Anúncio
Anúncio

INSP

INSP logo

Inspire Medical Systems, Inc.

92.20
USD
Patrocinado
-0.37
-0.40%
31 de dez., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

92.20

0.00
0.00%

Relatórios de Lucros INSP

Rácio de surpresa positiva

INSP separação 29 de 31 últimas estimativas.

94%

Próximo Relatório

Data do Próximo Relatório
09 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$267.98M
/
$0.67
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+19.37%
/
+97.06%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+11.79%
/
-41.23%

Inspire Medical Systems, Inc. earnings per share and revenue

On 03 de nov. de 2025, INSP reported earnings of 0.34 USD per share (EPS) for Q3 25, beating the estimate of -0.19 USD, resulting in a 271.72% surprise. Revenue reached 224.50 milhão, compared to an expected 224.88 milhão, with a -0.17% difference. The market reacted with a +15.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 analistas forecast an EPS of 0.67 USD, with revenue projected to reach 267.98 milhão USD, implying an aumentar of 97.06% EPS, and aumentar of 19.37% in Revenue from the last quarter.
FAQ
For Q3 2025, Inspire Medical Systems, Inc. reported EPS of $0.34, beating estimates by 271.72%, and revenue of $224.50M, -0.17% below expectations.
The stock price moved up 15.33%, changed from $73.71 before the earnings release to $85.01 the day after.
The next earning report is scheduled for 09 de fev. de 2026.
Based on 19 analistas, Inspire Medical Systems, Inc. is expected to report EPS of $0.67 and revenue of $267.98M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio